Biohit Oyj

Biohit Oyj is a Helsinki-based biotechnology company founded in 1988, specializing in medical diagnostics and preventive healthcare solutions to enhance health and prevent diseases. Biohit Oyj develops innovative diagnostic solutions targeted at enhancing healthcare quality. The company was founded in Helsinki, Finland in 1988. The founder's history is not available.

Biohit has evolved its business strategy to focus on gastrointestinal health and rapid testing for diseases such as celiac disease, serving a mainly European market. Biohit Oyj specializes in innovative biotechnology solutions aimed at enhancing health and preventing diseases. The company’s core product offerings revolve around medical diagnostics and preventive healthcare technologies, particularly focusing on areas such as early disease detection and gastrointestinal health. Notably, Biohit has developed rapid testing solutions for conditions like celiac disease and other gastrointestinal disorders, utilizing advanced methodologies that allow for non-invasive diagnostics.

Their products are utilized by healthcare professionals and laboratories, primarily in European markets including the United Kingdom and Italy, where they address critical diagnostic needs in clinical settings. With a mission centered on improving quality of life by preventing serious illnesses, Biohit aims to cater to a diverse client base that includes hospitals, clinics, and research institutions. Biohit generates revenue through the sale of its diagnostic products and services, employing a direct-to-consumer and business-to-business transaction model. The company typically engages in partnerships with healthcare providers and institutions, facilitating access to its diagnostic tools.

Transactions are structured around bulk orders by medical facilities, as well as potential subscription models for ongoing supply agreements. While specific pricing details for individual products are not publicly disclosed, the company’s flagship diagnostics, such as its rapid testing kits, are positioned to meet the needs of health professionals seeking reliable and effective solutions for patient care. Biohit's revenue is supported by its strategic presence in key European markets, allowing it to capitalize on the growing demand for innovative health technologies.